Submitted:
06 July 2026
Posted:
13 July 2026
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Participants
2.2. Eligibility Criteria
- A formal diagnosis of idiopathic PD confirmed by a neurologist according to established clinical criteria;
- Disease severity between stage I and III on the Hoehn and Yahr scale [33];
- Ability to walk independently without assistive devices for at least 10 minutes; and
- Clinical stability of the antiparkinsonian pharmacological regimen prior to enrollment, with no major medication changes during the intervention period.
2.3. Study Design and Allocation Procedure
- A Control group that maintained standard activities of daily living;
- An RT tango-based therapy group; or
- An APA group.
2.4. Interventions
2.4.1. Riabilitango® Tango-Based Therapy Protocol (RT)
2.4.2. Adapted Physical Activity Protocol
2.5. Instrumental Postural, Stabilometric, and Gait Assessment
2.5.1. Postural and Stabilometric Assessment (ProKin System)
2.5.2. Instrumental Gait Analysis (Walker View)
2.6. Study Design Quality Control
2.7. Statistical Analysis
3. Results
3.1. Participant Flow, Adherence, and Safety
3.2. Static Postural Stability and Balance Outcomes
3.3. Functional Gait Capacity and Walking Performance
3.4. Kinematic Predictors, Bivariate Correlations, and Biomechanical Coupling
4. Discussion
4.1. Statement of Principal Findings
4.2. The APA Paradox: Postural Stability vs. Dynamic Gait and Neuroplasticity
4.3. Biomechanical Decoupling and Adaptive Loading Mechanisms
4.4. Support from Meta-Analyses and Clinical Implications
5. Study Limitations
6. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Marsden, C. D. Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry 1994, 57, 672–681.
- Macht, M.; Kaussner, Y.; Möller, J. C.; et al. Predictors of freezing in Parkinson’s disease: A survey of 6,620 patients. Movement Disorders 2007, 22, 953–956.
- Liu, W.-Y.; Tung, T.-H.; Zhang, C.; Shi, L. Systematic review for the prevention and management of falls and fear of falling in patients with Parkinson’s disease. Brain Behav. 2022, 12, e2690.
- Reijnders, J. S. A. M.; Ehrt, U.; Weber, W. E. J.; et al. A systematic review of prevalence studies of depression in Parkinson’s disease. Movement Disorders 2008, 23, 183–189.
- Broen, M. P. G.; Narayen, N. E.; Kuijf, M. L.; et al. Prevalence of anxiety in Parkinson’s disease: A systematic review and meta-analysis. Movement Disorders 2016, 31, 1125–1133.
- Sveinbjornsdottir, S. The clinical symptoms of Parkinson’s disease. J. Neurochem. 2016, 139, 318–324.
- van Uem, J. M. T.; Marinus, J.; Canning, C.; et al. Health-Related Quality of Life in patients with Parkinson’s disease—A systematic review based on the ICF model. Neurosci. Biobehav. Rev. 2016, 61, 26–34.
- Dorsey, E. R.; Elbaz, A.; Nichols, E.; et al. Global, regional, and national burden of Parkinson’s disease, 1990–2016. Lancet Neurol. 2018, 17, 939–953.
- Deuschl, G.; Beghi, E.; Fazekas, F.; et al. The burden of neurological diseases in Europe. Lancet Public Health 2020, 5, e551–e567.
- Przedborski, S. Pathogenesis of nigral cell death in Parkinson’s disease. Parkinsonism Relat. Disord. 2005, 11 (Suppl 1), S3–S7.
- Shahmoradian, S. H.; Lewis, A. J.; Genoud, C.; et al. Lewy pathology in Parkinson’s disease consists of crowded organelles and lipid membranes. Nat. Neurosci. 2019, 22, 1099–1109.
- Aradi, S. D.; Hauser, R. A. Medical Management and Prevention of Motor Complications in Parkinson’s Disease. Neurotherapeutics 2020, 17, 1339–1365.
- Trinh, J.; de Vries, N. M.; Chan, P.; et al. The role of lifestyle interventions in symptom management and disease modification in Parkinson’s disease. Lancet Neurol. 2026, 25, 90–102.
- Wilson, A. C.; Pountney, D. L.; Khoo, T. K. Therapeutic Mechanisms of Exercise in Parkinson’s Disease. Int. J. Mol. Sci. 2025, 26, 4860.
- Langeskov-Christensen, M.; Franzén, E.; Grøndahl Hvid, L.; Dalgas, U. Exercise as medicine in Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry 2024, 95, 1077–1088.
- Ernst, M.; Folkerts, A. K.; Gollan, R.; et al. Physical exercise for people with Parkinson’s disease: a systematic review and network meta-analysis. Cochrane Database Syst. Rev. 2023, 1, CD013856.
- Osborne, J. A.; Botkin, R.; Colon-Semenza, C.; et al. Physical Therapist Management of Parkinson Disease: A Clinical Practice Guideline. Phys. Ther. 2022, 102, pzab302.
- Hirsch, M. A.; Farley, B. G. Exercise and neuroplasticity in persons living with Parkinson’s disease. Eur. J. Phys. Rehabil. Med. 2009, 45, 215–229.
- Speelman, A. D.; van de Warrenburg, B. P.; van Nimwegen, M.; et al. How might physical activity benefit patients with Parkinson disease? Nat. Rev. Neurol. 2011, 7, 528–534.
- Petzinger, G. M.; Fisher, B. E.; McEwen, S.; et al. Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson’s disease. Lancet Neurol. 2013, 12, 716–726.
- Goodwin, V. A.; Richards, S. H.; Taylor, R. S.; et al. The effectiveness of exercise interventions for people with Parkinson’s disease. Movement Disorders 2008, 23, 631–640.
- Alberts, J. L.; Rosenfeldt, A. B. The Universal Prescription for Parkinson’s Disease: Exercise. J. Parkinson’s Dis. 2020, 10 (s1), S21–S27.
- Wallin, A.; Franzén, E.; Studsgaard, J.; et al. Balance exercise interventions in Parkinson’s disease: A systematic mapping review. Parkinsonism Relat. Disord. 2025, 133, 107310.
- Frenkel-Toledo, S.; Giladi, N.; Peretz, C.; et al. Treadmill walking as an external pacemaker to improve gait rhythm and stability in Parkinson’s disease. Movement Disorders 2005, 20, 1109–1114.
- Mehrholz, J.; Kugler, J.; Storch, A.; et al. Treadmill training for patients with Parkinson’s disease. Cochrane Database Syst. Rev. 2015, No. CD007830.
- Hackney, M. E.; Kantorovich, S.; Levin, R.; Earhart, G. M. Effects of tango on functional mobility in Parkinson’s disease: a preliminary study. J. Neurol. Phys. Ther. 2007, 31, 173–179.
- Hackney, M.; Earhart, G. M. Effects of dance on movement control in Parkinson’s disease. J. Rehabil. Med. 2009, 41, 475–481.
- Giorgi, F.; Platano, D.; Berti, L.; et al. Dancing Towards Stability: The Therapeutic Potential of Argentine Tango for Balance and Mobility in Parkinson’s Disease. Diseases 2025, 13, 82.
- McNeely, M. E.; Duncan, R. P.; Earhart, G. M. Impacts of dance on non-motor symptoms, participation, and quality of life in Parkinson disease and healthy older adults. Maturitas 2015, 82(4), 336–341.
- Duncan, R. P.; Earhart, G. M. Randomized controlled trial of community-based dancing to modify disease progression in Parkinson disease. Neurorehabil. Neural Repair 2012, 26, 132–143.
- Zhang, W.; Ling, Y.; Chen, Z.; et al. Wearable sensor-based quantitative gait analysis in Parkinson’s disease patients. npj Digit. Med. 2024, 7, 169.
- Russo, M.; Amboni, M.; Pisani, N.; et al. Biomechanics Parameters of Gait Analysis to Characterize Parkinson’s Disease: A Scoping Review. Sensors 2025, 25, 338.
- Hoehn, M. M.; Yahr, M. D. Parkinsonism: onset, progression and mortality. Neurology 1967, 17, 427–442.
- Opara, J.; Małecki, A.; Małecka, E.; Socha, T. Motor assessment in Parkinson’s disease. Ann. Agric. Environ. Med. 2017, 24, 411–415.
- American College of Sports Medicine. ACSM’s Guidelines for Exercise Testing and Prescription, 10th ed.; Wolters Kluwer: Philadelphia, 2018.
- Bravi, M.; Massaroni, C.; Santacaterina, F.; et al. Validity analysis of WalkerView™ instrumented treadmill for measuring spatiotemporal and kinematic gait parameters. Sensors 2021, 21, 4795.
- Cattaneo, D.; Jonsdottir, J. Sensory impairments in quiet standing in subjects with multiple sclerosis. Mult. Scler. J. 2009, 15, 59–67.
- Stożek, J.; Rudzińska, M.; Pustułka-Piwnik, U.; et al. The effect of the rehabilitation program on balance, gait, physical performance and trunk rotation in Parkinson’s disease. Aging Clin. Exp. Res. 2016, 28, 1169–1177.
- Aktar, B.; Donmez Colakoglu, B.; Balci, B. Does the postural stability of patients with Parkinson’s disease affect the physical activity? Int. J. Rehabil. Res. 2020, 43, 41–47.
- Lorenzo-García, P.; Cavero-Redondo, I.; et al. Effects of physical exercise interventions on balance, postural stability and general mobility in Parkinson’s disease: a network meta-analysis. J. Rehabil. Med. 2024, 56, jrm10329.
- World Health Organization. WHO guidelines on physical activity and sedentary behaviour; WHO: Geneva, 2020.
- American College of Sports Medicine. ACSM’s Exercise Management for Persons with Chronic Diseases and Disabilities, 2nd ed.; Human Kinetics: Champaign, IL, 2003.
- Valenzano, A. A.; Vasco, P.; D’Orsi, G.; et al. Impact of Exercise Therapy in ERAS Prehabilitation for Major Surgery: A Systematic Review. Sports 2025, 13(9), 315.






| Characteristic | Total (N=27) | APA (N=10) | RT (N=10) | Control (N=7) |
| Age (years) | 70 (9) | 70 (7) | 68 (8) | 71 (12) |
| Weight (kg) | 75 (14) | 70 (12) | 79 (18) | 75 (11) |
| Sex | ||||
| – Female | 8 (30%) | 1 (10%) | 3 (30%) | 4 (57%) |
| – Male | 19 (70%) | 9 (90%) | 7 (70%) | 3 (43%) |
| Hoehn & Yahr Stage | ||||
| – Stage 1 | 3 (11%) | 0 (0%) | 1 (10%) | 2 (29%) |
| – Stage 1.5 | 2 (7.4%) | 2 (20%) | 0 (0%) | 0 (0%) |
| – Stage 2 | 5 (19%) | 3 (30%) | 1 (10%) | 1 (14%) |
| – Stage 2.5 | 11 (41%) | 3 (30%) | 5 (50%) | 3 (43%) |
| – Stage 3 | 6 (22%) | 2 (20%) | 3 (30%) | 1 (14%) |
| Variable Code | System | Full Parameter Name | Unit |
| Group | Demographics | Intervention Group | 1=APA; 2=RT; 3=Control |
| t | Timeline | Assessment Time Point | 1=T0; 2=T1 |
| SEEO_A | ProKin | CoP Ellipse Area (EO) | mm2 |
| SEEO_P | ProKin | CoP Perimeter (EO) | mm |
| SEEO_V | ProKin | Mean Sway Velocity (EO) | mm/s |
| SEEC_A | ProKin | CoP Ellipse Area (EC) | mm2 |
| SEEC_P | ProKin | CoP Perimeter (EC) | mm |
| SEEC_V | ProKin | Mean Sway Velocity (EC) | mm/s |
| DE_TSI | ProKin | Total Stability Index | Degrees |
| PA_P.S.I.AVG_total | ProKin | Mean Postural Load Distr. | % |
| GA_D | Walker View | Total Walking Distance | km |
| VO CoG | Walker View | Vert. Oscillation of CoG | cm |
| ROM_H_R_MAX | Walker View | Right Hip Max ROM | Degrees |
| ROM_H_L_MAX | Walker View | Left Hip Max ROM | Degrees |
| ROM_K_R_MAX | Walker View | Right Knee Max ROM | Degrees |
| ROM_K_L_MAX | Walker View | Left Knee Max ROM | Degrees |
| Comparison | Outcome | Cohen’s d | Magnitude | Interpretation |
| APA vs. Control | Sway Area | 1.15 | Large | Substantial reduction in sway |
| RT vs. Control | Sway Area | 0.88 | Large | Prominent reduction in sway |
| APA vs. RT | Sway Area | 0.04 | Negligible | Comparable static profiles |
| APA vs. Control | Gait Distance | 2.17 | Huge | Marked increase in walking distance |
| APA vs. RT | Gait Distance | 1.50 | Very Large | Marked difference in favor of APA |
| RT vs. Control | Gait Distance | 0.67 | Medium | Moderate difference in walking gain |
| Correlated Variables | Pearson r | p-value | Significance |
| Walking Distance vs. Left Hip ROM | 0.283 | .038 | * |
| Walking Distance vs. Right Hip ROM | 0.312 | .021 | * |
| Walking Distance vs. Left Knee ROM | 0.366 | .006 | ** |
| Walking Distance vs. Right Knee ROM | 0.380 | .004 | ** |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).